New forum aims to address psoriasis awareness and treatment in Africa.

  • First Forum dedicated to psoriasis in Africa
  • Focus on raising awareness about psoriasis
  • Call for urgent action and improved treatment options

The International Federation of Psoriasis Associations (IFPA) has launched the first Africa Forum on Psoriasis, emphasizing the urgent need for increased awareness and action regarding this often-overlooked skin disease. Psoriasis affects millions across the continent, yet remains inadequately addressed in both healthcare systems and public discourse. The forum aims to mobilize stakeholders to advocate for better treatment and support for affected individuals.

During the forum, experts and advocates will discuss the complexities of psoriasis management in Africa, including challenges in diagnosis, treatment access, and the stigma surrounding the condition. Attendees will work together to develop actionable strategies to enhance patient care and mental health support for those living with psoriasis. The forum serves as a critical platform to unite various health organizations and ensure that psoriasis is recognized as a significant public health issue.

Recognizing the need for comprehensive action, the IFPA has called on governments, healthcare professionals, and civil society to collaborate in addressing psoriasis effectively. This initiative reflects a broader commitment to improving health outcomes for individuals with skin diseases across Africa, spotlighting the importance of education and awareness in combating this condition.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

Innovative automation enhances cancer research and immunological studies. AI-powered tools improve research…

Pharmacelera Raises $6M to Expand in US and Enhance Drug Discovery Platform

Funding will support growth and technological advancements in drug discovery. Pharmacelera has…

WuXi Biologics and Vertex Enter Research Agreement for T-Cell Engager

Collaboration focuses on advancing T-cell engager therapies for cancer treatment WuXi Biologics…

Services PMI at 53.8 in January 2026, According to ISM Report

January sees strong growth in services sector as PMI remains robust. Services…